These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 3631461)

  • 41. Radioaerosol Pulmonary Deposition Using Mesh and Jet Nebulizers During Noninvasive Ventilation in Healthy Subjects.
    Galindo-Filho VC; Ramos ME; Rattes CS; Barbosa AK; Brandão DC; Brandão SC; Fink JB; de Andrade AD
    Respir Care; 2015 Sep; 60(9):1238-46. PubMed ID: 26106207
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Scintigraphic assessment of radio-aerosol pulmonary deposition with the acapella positive expiratory pressure device and various nebulizer configurations.
    Mesquita FO; Galindo-Filho VC; Neto JL; Galvão AM; Brandão SC; Fink JB; Dornelas-de-Andrade A
    Respir Care; 2014 Mar; 59(3):328-33. PubMed ID: 23920214
    [TBL] [Abstract][Full Text] [Related]  

  • 43. In Vitro Characterization of the eFlow Closed System Nebulizer with Glycopyrrolate Inhalation Solution.
    Pham S; Ferguson GT; Kerwin E; Goodin T; Wheeler A; Bauer A
    J Aerosol Med Pulm Drug Deliv; 2018 Jun; 31(3):162-169. PubMed ID: 29125918
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Positive expiratory pressure changes aerosol distribution in patients with cystic fibrosis.
    Laube BL; Geller DE; Lin TC; Dalby RN; Diener-West M; Zeitlin PL
    Respir Care; 2005 Nov; 50(11):1438-44. PubMed ID: 16253150
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [The role of bronchial responsiveness to leukotrienes in antigen-induced immediate and late asthmatic response].
    Yamai T; Watanabe S; Motojima S; Numao T; Amagai M; Otsuka T; Toda M; Fukuda T; Makino S
    Nihon Kyobu Shikkan Gakkai Zasshi; 1992 Sep; 30(9):1687-94. PubMed ID: 1447845
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Use of functional respiratory imaging to characterize the effect of inhalation profile and particle size on lung deposition of inhaled corticosteroid/long-acting β2-agonists delivered via a pressurized metered-dose inhaler.
    Van Holsbeke C; De Backer J; Vos W; Marshall J
    Ther Adv Respir Dis; 2018; 12():1753466618760948. PubMed ID: 29499614
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Importance of evaporative water losses during standardized nebulized inhalation provocation tests.
    Cockcroft DW; Hurst TS; Gore BP
    Chest; 1989 Sep; 96(3):505-8. PubMed ID: 2486186
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Effect of nebulised aerosol size on lung deposition in patients with mild asthma.
    Clay MM; Clarke SW
    Thorax; 1987 Mar; 42(3):190-4. PubMed ID: 3303427
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Electrolyte type and nozzle composition affect the process of vibrating-membrane nebulization.
    Beck-Broichsitter M; Oesterheld N
    Eur J Pharm Biopharm; 2017 Oct; 119():11-16. PubMed ID: 28499855
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Characterization of heparin aerosols generated in jet and ultrasonic nebulizers.
    Bendstrup KE; Newhouse MT; Pedersen OF; Jensen JI
    J Aerosol Med; 1999; 12(1):17-25. PubMed ID: 10351126
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Lung deposition in cystic fibrosis patients using an ultrasonic or a jet nebulizer.
    Köhler E; Sollich V; Schuster-Wonka R; Hühnerbein J
    J Aerosol Med; 2003; 16(1):37-46. PubMed ID: 12737683
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Effect of pranlukast, an oral leukotriene receptor antagonist, on leukotriene D4 (LTD4) challenge in normal volunteers.
    O'Shaughnessy TC; Georgiou P; Howland K; Dennis M; Compton CH; Barnes NC
    Thorax; 1997 Jun; 52(6):519-22. PubMed ID: 9227717
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Measurement of PC20 histamine with the use of two different nebulizers and measurement of FEV1 and PEF.
    Iversen M; Harving H; Pedersen B
    Allergy; 1991 Apr; 46(3):213-6. PubMed ID: 2058817
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Lung deposition and respirable mass during wet nebulization.
    Sangwan S; Condos R; Smaldone GC
    J Aerosol Med; 2003; 16(4):379-86. PubMed ID: 14977428
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Benefits of nebulized therapy: basic concepts].
    Máiz Carro L; Wagner Struwing C
    Arch Bronconeumol; 2011 Jun; 47 Suppl 6():2-7. PubMed ID: 21703472
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Ultrasonically nebulized hypertonic saline as a provocation agent in asthmatics].
    Sun B
    Zhonghua Jie He He Hu Xi Za Zhi; 1991 Apr; 14(2):98-100, 128. PubMed ID: 1879027
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Histamine bronchial challenge: effect on regional ventilation and aerosol deposition.
    Clague H; Ahmad D; Chamberlain MJ; Morgan WK; Vinitski S
    Thorax; 1983 Sep; 38(9):668-75. PubMed ID: 6623420
    [TBL] [Abstract][Full Text] [Related]  

  • 58. A gamma scintigraphy study to investigate lung deposition and clearance of inhaled amikacin-loaded liposomes in healthy male volunteers.
    Weers J; Metzheiser B; Taylor G; Warren S; Meers P; Perkins WR
    J Aerosol Med Pulm Drug Deliv; 2009 Jun; 22(2):131-8. PubMed ID: 19422313
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Deposition of coarse particles in cystic fibrosis: model predictions versus experimental results.
    Brown JS; Bennett WD
    J Aerosol Med; 2004; 17(3):239-48. PubMed ID: 15625816
    [TBL] [Abstract][Full Text] [Related]  

  • 60. A rapid dosimetric method with controlled tidal breathing for histamine challenge. Repeatability and distribution of bronchial reactivity in a clinical material.
    Sovijärvi AR; Malmberg LP; Reinikainen K; Rytilä P; Poppius H
    Chest; 1993 Jul; 104(1):164-70. PubMed ID: 8325062
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.